e-Motivación: Developing and Pilot Testing an App to Improve Latinos' Screening Colonoscopy Rates
2 other identifiers
interventional
42
1 country
1
Brief Summary
Among Latinos, a fast growing and underserved population, Colorectal Cancer (CRC) is the third leading cause of cancer death in men and in women. Compared to non-Latino whites, Latinos are less likely to be diagnosed with localized CRC and more likely to be diagnosed with advanced stage disease. Of the recommended CRC screening tests, a colonoscopy allows for both the detection and removal of precancerous and cancerous polyps. Although screening colonoscopies can detect and prevent CRC, more than half of Latinos have not received a screening colonoscopy within the recommended time frame (one screening colonoscopy per ten years). The purpose of this study is to develop and begin to test an electronically-delivered motivational interviewing progressive web application (e-MI app), called Motívate. The Motívate app will be offered in both English and Spanish to patients who self-identify as Latino/a/x, after they receive a referral for a screening colonoscopy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable colorectal-cancer
Started Aug 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 23, 2021
CompletedFirst Posted
Study publicly available on registry
August 3, 2021
CompletedStudy Start
First participant enrolled
August 19, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 27, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
April 27, 2023
CompletedResults Posted
Study results publicly available
June 18, 2024
CompletedJune 18, 2024
May 1, 2024
1.7 years
July 23, 2021
April 23, 2024
May 24, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Colonoscopy Completion
Screening colonoscopy completion status in medical charts six months after participants are enrolled in the study.
Six months after enrollment
Study Arms (2)
Motívate group
EXPERIMENTALParticipants will engage with an app on an iPad, smartphone or computer.
Control Group
ACTIVE COMPARATORParticipant receive a link to watch a general health information video.
Interventions
The Motívate app can be used in English or Spanish and involves four sequential phases. 1) The engaging phase uses videos to welcome participants. 2) Patients willing to discuss the decision to have a screening colonoscopy will answer multiple-choice questions on colorectal cancer prevention - completing the focusing phase. Optional videos will offer additional information. 3) The evoking phase consists of interactive Motivational Interviewing exercises to help participants elicit motivations to get a screening colonoscopy. 4) During the planning phase, participants will view a video that will discuss the steps needed to prepare for the colonoscopy.
Eligibility Criteria
You may qualify if:
- Self-identified as Latino/a/x;
- English or Spanish-speaking;
- Received a physician referral for a screening colonoscopy;
- Has access to a tablet, smartphone, or computer with working Internet.
You may not qualify if:
- Hearing or vision impaired;
- Aim 1 or 2 participant.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Icahn School of Medicine at Mount Sinailead
- National Institute on Aging (NIA)collaborator
- Department of Health and Human Servicescollaborator
- University of Virginiacollaborator
Study Sites (1)
Icahn School of Medicine at Mount Sinai
New York, New York, 10029, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Sarah Miller
- Organization
- Icahn School of Medicine at Mount Sinai
Study Officials
- PRINCIPAL INVESTIGATOR
Sarah J. Miller, PsyD
Icahn School of Medicine at Mount Sinai
Publication Agreements
- PI is Sponsor Employee
- Yes
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
July 23, 2021
First Posted
August 3, 2021
Study Start
August 19, 2021
Primary Completion
April 27, 2023
Study Completion
April 27, 2023
Last Updated
June 18, 2024
Results First Posted
June 18, 2024
Record last verified: 2024-05
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, ICF
- Time Frame
- Immediately following publication. No end date.
- Access Criteria
- Researchers who provide a methodologically sound proposal. Any purpose. Proposals should be directed to sarah.miller@mssm.edu. To gain access, data requestors will need to sign a data access agreement. Upon request, we will provide the de-identified dataset to qualified investigators under a Data Use Agreement that provides for: 1) a commitment to using the data only for research purposes; (2) a commitment to securing the data using appropriate computer technology; and, (3) a commitment to destroying or returning the data after analyses are completed.
All of the individual participant data collected during the trial, after deidentification.